Article Information
vol. 7 no. 4
Published By
Online ISSN
History
- Received April 11, 2021
- Accepted July 19, 2021
- Published online October 4, 2021.
Article Versions
- previous version (August 26, 2021 - 07:34).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Divya Mohan1,
- Holly R. Keir2,
- Hollian Richardson2,
- David Mayhew1,
- Joseph Boyer1,
- Marc P. van der Schee3,
- Max D. Allsworth3,
- Bruce E. Miller1,
- Ruth Tal-Singer1 and
- James D. Chalmers2⇑
- 1GSK R&D, Collegeville, PA, USA
- 2Ninewells Clinical Research Centre, University of Dundee, Dundee, UK
- 3Owlstone Medical, Cambridge, UK
- Corresponding author: James D. Chalmers (j.chalmers{at}dundee.ac.uk)
Funding
GlaxoSmithKline
GSK study 207551
Article usage
Altmetrics
Vol 7 Issue 4
Table of Contents
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial
